Organization · Tulsa and Oklahoma ecosystem
Otologic Pharmaceutics
An Oklahoma City biotechnology company developing treatments for hearing loss and related disorders. Its research includes oral drug candidates and approaches to restoring sensory cells in the inner ear. i2E and Oklahoma Life Science Fund list it in their portfolios.
For example: A founder studying hearing-health biotechnology reads Otologic Pharmaceutics' research and development pipeline.
Official site: otologicpharma.com
Connects to 5
- Startup ecosystem Concept
- i2E Organization, nonprofit
- Oklahoma Seed Capital Fund Investor
- Accelerate Oklahoma Fund Investor
- OLSF Ventures Investor